At Kendle, we know that establishing a safety profile for your new drug is paramount in achieving successful approval to market your product. Kendle’s safety group is skilled in managing adverse events that occur in clinical trials, while ensuring patient safety and providing guidance to the physicians conducting these important protocols.
Our team of safety experts is located across the globe and offers local expertise and extensive experience in the management of Adverse Events (AEs) in areas such as oncology, arthritis and related diseases, endocrinology diseases and many more. Our adverse event management system (ARGUS ) also enables us to receive AE reports directly from clinical trial sites that have been processed in regional locations, allowing for efficient generation.
Our therapeutic expertise and international network of physicians make Kendle the ideal partner to ensure your product has the most robust and accurate safety data possible.